Question: Consider the Collaboration Agreement between Astellas Pharma Inc. and FibroGen, Inc. for Development of Anemia Treatments; What licenses are granted under this contract?
Relevant contract clauses:
[{"span": [59284, 59532], "answer": "FG shall have access to and the right to use for any purpose, any Data developed by or on behalf of Astellas or its Affiliates or Sublicensees in the course of the Development Program with respect to indications within the Field for Lead Compounds.", "file_path": "cuad/FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.txt"}, {"span": [59873, 60792], "answer": "Astellas shall have access to and the right to use solely for the purpose of this Agreement, any Data developed by or on behalf of FG or its Affiliates or Sublicensees with respect to Lead Compounds in connection with the Field (i) to the extent necessary to support the application to the regulatory authority in the Astellas Territory or to fulfill other Japanese Ministry of Health, Labor and Welfare regulatory requirements, or (ii) if not necessary to support such application or to fulfill such Japanese Ministry of Health, Labor and Welfare regulatory requirements, to the extent FG is permitted subject to FG's third party obligations; provided that FG shall [ * ] negotiate the availability of such Data to Astellas from such Sublicensee, and provided, further, that Astellas agrees not to use or disclose to third parties any such data for purposes outside the Field except as authorized under this Agreement.", "file_path": "cuad/FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.txt"}, {"span": [102473, 102776], "answer": "Subject to the terms and conditions of this Agreement including Article 12 above, FG hereby grants to Astellas an exclusive license under the FG Technology to: use, package, sell, have sold, import, market and otherwise distribute the Lead Compounds for use solely in the Field in the Astellas Territory", "file_path": "cuad/FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.txt"}, {"span": [104134, 104504], "answer": "Following the signing of this Agreement, FG agrees to negotiate in good faith with Astellas for a license to develop compounds for the Expanded Field in the Astellas Territory, exclusively for a period of [ * ] following such date, and non- exclusively thereafter until the execution of a license agreement with a third party to develop compounds for the Expanded Field.", "file_path": "cuad/FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.txt"}, {"span": [105012, 105827], "answer": "Subject to Section 14.1.1, title to all inventions and other intellectual property made related to (i) the Development Program, (ii) the Lead Compounds, (iii) FG Technology or FG Confidential Information, (iv) the Field, or (v) the Expanded Field (subsections 14.1(i)-(v), collectively, the \"Protected Field\") shall be owned by or is hereby assigned to FG; provided, however that Astellas shall own inventions of general applicability relating solely to drug delivery systems created exclusively by Astellas under subsection 14.1(i), excluding inventions related to or based on subsections 14.1(ii), (iii), (iv), or (v), and provided, further, that Astellas hereby grants to FG a worldwide, fully paid non-exclusive license with the right to sublicense to practice such inventions with respect to the FG Technology.", "file_path": "cuad/FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.txt"}, {"span": [105946, 106610], "answer": "Notwithstanding Section 14.1, in the event that Astellas develops, completely independently from any FG Technology and/or any other FG materials, confidential information, intellectual property or other related information provided by or on behalf of FG to Astellas under this Agreement or any other agreement between FG and Astellas relating to the subject matter hereof, any inventions or intellectual property rights related to the Field or the Expanded Field, [ * ], Astellas shall own such intellectual property and hereby grants to FG and its Sublicensees a non-exclusive, royalty-free, irrevocable license to such intellectual property for the FG Territory.", "file_path": "cuad/FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.txt"}, {"span": [142128, 142463], "answer": "In the event of a termination of this Agreement, FG shall have an irrevocable, exclusive, license, with the right to grant and authorize sublicenses, to any trademarks used by Astellas in association with the Lead Compounds hereunder to make, use, sell, import and otherwise exploit products within the Field in the Astellas Territory.", "file_path": "cuad/FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.txt"}]